Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 727 | 730 | 773 | 1,744 | 11 |
| Receivables | 4,864 | 5,771 | 5,487 | 4,518 | 2,762 |
| Inventories | 17,062 | 12,167 | 9,590 | 9,783 | 9,635 |
| TOTAL | $23,002 | $19,113 | $16,531 | $16,707 | $12,800 |
| Non-Current Assets | |||||
| PPE Net | 2,085 | 1,703 | 1,466 | 1,529 | 1,594 |
| Intangibles | 20,301 | 26,389 | 23,347 | 23,349 | 23,334 |
| Other Non-Current Assets | 5,990 | 11,278 | 10,541 | 10,623 | 9,493 |
| TOTAL | $28,376 | $39,370 | $35,354 | $35,501 | $34,421 |
| Total Assets | $51,378 | $58,483 | $51,885 | $52,208 | $47,221 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,020 | 11,995 | 11,623 | 8,711 | 8,114 |
| Accounts payable and accrued liabilities | 4,958 | 5,476 | 3,599 | 4,383 | 3,304 |
| Accrued Expenses | N/A | N/A | 923 | N/A | N/A |
| Other current liabilities | 1,397 | N/A | N/A | N/A | N/A |
| TOTAL | $22,924 | $20,020 | $16,971 | $14,657 | $12,550 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,344 | 7,229 | 5,827 | 7,541 | 6,323 |
| Other Non-Current Liabilities | 6,657 | 4,077 | 2,813 | 3,038 | 31,406 |
| TOTAL | $16,001 | $11,306 | $8,640 | $10,579 | $37,729 |
| Total Liabilities | $38,925 | $31,326 | $25,611 | $25,236 | $50,268 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,454 | 8,306 | 5,581 | 5,190 | N/A |
| Common Shares | 4 | 3 | 3 | 3 | N/A |
| Retained earnings | -218,037 | -201,249 | -199,235 | -198,535 | -196,102 |
| Other shareholders' equity | -1 | 0 | 0 | 0 | 0 |
| TOTAL | $12,453 | $27,157 | $26,274 | $26,972 | $-3,058 |
| Total Liabilities And Equity | $51,378 | $58,483 | $51,885 | $52,208 | $47,210 |